drugset / Trial / NCT02695381

Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness

NCT02695381 ↗

Phase 3 Completed 100 enrolled MEDRx USA, Inc.
RandomizedFactorialTriple-blindTreatment

Summary

This study evaluate the efficacy and safety of Etodolac-lidocaine topical patch applied one time daily when compared with placebo in the treatment of acute Delayed Onset Muscle Soreness (DOMS) of the upper limbs.

Timeline

Start
2016-03
Primary completion
2016-08
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Etodolac-lidocaine Unknown — Topical

Indications

No indication recorded.